Novo Nordisk ADR (NYSE:NVO) does about 4.08M shares in volume on a normal day but saw 3122734 shares change hands in Monday trading. The company now has a market cap of 479.50B USD. Its current market price is $143.63, marking an increase of 0.52% compared to the previous close of $142.88. The 52 week high reached by this stock is $143.73 whilst the lowest price level in 52 weeks is $75.56.
Novo Nordisk ADR (NVO) has a 20-day trading average at $135.95 and the current price is -0.07% off the 52-week high compared with 90.09% distance from its 52-week low. The 50-day simple moving average of the closing price is $129.88 and its 200-day simple moving average is $112.18. If we look at the stock’s price movements over the week, volatility stands at 1.83%, which decreases to 1.60% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 73.79 to suggest the stock is overbought.
The consensus objective for the share price is $140.44, suggesting that the stock has a potential downside of -2.27% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on May 30, 2024 when Goldman initiated the stock to “Buy” and issued a price target of $156. Morgan Stanley initiated its price target at $120.
Novo Nordisk ADR (NVO) stock is up 5.91% over the week and 11.64% over the past month. Its price is 38.84% year-to-date and 80.16% over the past year.
To reach the target analysts have set, the stock logically needs to shrink -2.27 percent from here.
The company has a return on investment of 77.53% and return on equity of 99.99%. The price to earnings ratio (P/E ratio) amounts to 49.60 while the forward price to earnings ratio is 34.31. The beta has a value of 0.41. Price to book ratio is 44.71 and price to sales ratio is 13.50.
